Qiagen N.V.
QGEN- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001015820
No open-market purchases or sales by Qiagen N.V. insiders were filed in the last 90 days; 337 institutions reported holding it in 13F filings for Q2 2026, worth $5.68B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Qiagen N.V. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 278
- 0 vs. Q3 2023
- Shares held
- 139.7M
- +6.06M (+4.5%) vs. Q3 2023
- Total value
- $6.09B
- +$686.8M (+12.7%) vs. Q3 2023
- New holders
- 46
- 105 more added
- Sold out
- 46
- 90 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 337 | $5.68B |
| Q1 2026 | 346 | $5.02B |
| Q4 2025 | 322 | $6.77B |
| Q3 2025 | 339 | $6.84B |
| Q2 2025 | 318 | $7.23B |
| Q1 2025 | 300 | $5.92B |
| Q4 2024 | 325 | $6.60B |
| Q3 2024 | 330 | $7.05B |
| Q2 2024 | 305 | $6.22B |
| Q1 2024 | 282 | $5.83B |
| Q4 2023 | 278 | $6.09B |
| Q3 2023 | 279 | $5.40B |
| Q2 2023 | 283 | $6.14B |
| Q1 2023 | 288 | $6.23B |
| Q4 2022 | 300 | $6.76B |
| Q3 2022 | 297 | $5.73B |
| Q2 2022 | 289 | $6.11B |
| Q1 2022 | 294 | $6.39B |
| Q4 2021 | 302 | $7.40B |
| Q3 2021 | 267 | $6.77B |
| Q2 2021 | 259 | $5.98B |
| Q1 2021 | 276 | $5.97B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Qiagen N.V.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| L2 Asset Management, LLC | 0 | $0 | 0.00% | −9,354−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −9,268−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −8,582−100.0% | Sold out |
| Lumina Fund Management LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −6,570−100.0% | Sold out |
| Oak Family Advisors, LLC | 0 | $0 | 0.00% | −6,225−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Greenleaf Trust | 0 | $0 | 0.00% | −5,373−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,136−100.0% | Sold out |
| Briaud Financial Planning, Inc | 0 | $0 | 0.00% | −769−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −682−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −662−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −637−100.0% | Sold out |
| West Tower Group, LLC | 0 | $0 | 0.00% | −533−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −384−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −160−100.0% | Sold out |
| Authentikos Wealth Advisory, LLC | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Glass Jacobson Investment Advisors llc | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Forsta Ap-Fonden | 0 | $0 | 0.00% | −48,268−100.0% | Sold out |
| Column Capital Advisors, LLC | – | – | – | – | Not filed |